Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Current price $18.68
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Jul 2, 26 | Roth Capital |
Daily · Wilder smoothing
| maintain |
| Buy |
| Buy |
| Jul 2, 26 | Barrington Research | maintain | Outperform | Outperform |
| Jun 5, 26 | Barrington Research | maintain | Outperform | Outperform |
| Apr 2, 26 | Barrington Research | maintain | Outperform | Outperform |
| Mar 25, 26 | Barrington Research | maintain | Outperform | Outperform |
| Jan 20, 26 | Barrington Research | maintain | Outperform | Outperform |
| Jan 8, 26 | Barrington Research | maintain | Outperform | Outperform |
| Dec 11, 25 | Barrington Research | maintain | Outperform | Outperform |
| Nov 6, 25 | Barrington Research | maintain | Outperform | Outperform |
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 56.06 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 65.54 | Oscillator | Neutral |
| Williams %R (14) | -25.85 | Oscillator | Neutral |
| MACD (12, 26, 9) | 0.05 (Hist 0.14) | Oscillator | Strong Buy |
| Average Directional Index (14) | 22.03 (+DI 22.4 / -DI 16.7) | Trend | Buy |
| EMA 20 | 18.16 | MA | Buy |
| SMA 20 | 17.92 | MA | Strong Buy |
| EMA 50 | 18.66 | MA | Buy |
| SMA 50 | 18.48 | MA | Buy |
| SMA 200 | 19.65 | MA | Strong Sell |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Oct 18, 26 | Betjemann Jessica | officer: Executive VP and CFO | F-InKind | 287 @ $17.95 | $5.15K |
| Oct 18, 26 | Dom Colleen D | officer: EVP Operations | F-InKind | 224 @ $17.95 | $4.02K |
| Oct 18, 26 | Hatch Anthony Derek | officer: CAO, Controller and Treasurer | F-InKind | 126 @ $17.95 | $2.26K |
| Oct 18, 26 | Procter Holly | officer: President Enterprise Division | F-InKind | 130 @ $17.95 | $2.33K |
| Oct 18, 26 | Walker Paul S | officer: CEO | F-InKind | 1,451 @ $17.95 | $26.05K |
| Oct 18, 26 | Covey Michael Sean Merrill | officer: Chief Product Officer | F-InKind | 313 @ $17.95 | $5.62K |
| Sep 1, 26 | Buchanan John W. | officer: Executive VP, Education | 0 | — | |
| Sep 2, 26 | Covey Michael Sean Merrill | officer: President Education Division | F-InKind | 589 @ $20.35 | $11.99K |
TTM vs. 5-year historical average (annual ratios)
| Metric | FC | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 103.8x | 43.7x · sector 38.2x | Elevated |
| Forward P/E (FY26E) | 46.4x | EPS est. 0.40 | Discount |
| Price / Book | 4.9x | 6.7x | Discount |
| Price / Sales | 0.8x | 2.0x | Discount |
| EV / EBITDA | 12.1x | 15.7x | Discount |
| Return on equity | 4.3% | — | Weak |
| Gross margin | 73.1% | 76.6% | In line |
| Debt / Equity | 0.00 | 0.22 | Conservative |
| Piotroski / Altman Z | 6/9 | Z 2.85 | Grey zone |
Discounted cash flow model
Stock news · updated daily
SALT LAKE CITY--(BUSINESS WIRE)--Franklin Covey Co. (NYSE: FC), a global leadership and organizational performance partner that gives strategy the human edge, announced today that the conference call to review the Company's fourth quarter and fiscal year 2026 financial results will take place on Wednesday, November 4, 2026, at 5:00 p.m. ET (3:00 p.m. MT). The Company's financial results are expected to be released after the close of the market on Wednesday, November 4, 2026. Interested persons.
SALT LAKE CITY--(BUSINESS WIRE)-- #4DX--FranklinCovey Education Launches National Tour for The 4 Disciplines of Execution for Educators.
SALT LAKE CITY--(BUSINESS WIRE)-- #6CriticalPracticesForLeadingATeam--FranklinCovey and Simon & Schuster Release Expect A Lot, Care A Lot, Capturing a Decade of Learning from Client Transformations.
SALT LAKE CITY--(BUSINESS WIRE)-- #AcademicImprovement--FranklinCovey Appoints John Buchanan Executive Vice President, Education as Sean Covey is Named Chief Product Officer.
Franklin Covey NYSE: FC outlined a presentation-development framework aimed at helping professionals move audiences from receiving information to taking action during a webinar led by Darren, an executive coach and senior leadership consultant at the company.
[url="]Ironwood Pharmaceuticals, Inc.[/url] (Nasdaq: IRWD), a biotechnology company developing and commercializing lifeâchanging therapies for people living w
On June 30, 2026, Chuck Royce (Trades, Portfolio)'s firm executed a reduction of 161,348 shares in Franklin Covey Co (NYSE: FC), representing a -15.47% change in
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Jul 1, 2026 | 0.24 | 0.27 | Beat 12.5% | $67.81M |
| Apr 1, 2026 | 0.03 | -0.17 | Miss -780.0% | $59.65M |
| Jan 7, 2026 | 0.03 | 0.07 | Beat 133.3% | $64.05M |
| Nov 5, 2025 | 0.43 | 0.34 | Miss -20.9% | $71.25M |
| Jul 2, 2025 | -0.08 | 0.18 | Beat 325.0% | $67.12M |
| Apr 2, 2025 | -0.11 | -0.08 | Beat 27.3% | $59.61M |
FY2025 · 10-K disclosure
FY2025 · 10-K disclosure
| 4 | Oct 20, 2026 | 2026-10-20 16:39:56 | View |
| 4 | Oct 20, 2026 | 2026-10-20 16:37:30 | View |
| 4 | Oct 20, 2026 | 2026-10-20 16:35:04 | View |
| 3 | Sep 9, 2026 | 2026-09-09 17:41:56 | View |
| 4 | Sep 3, 2026 | 2026-09-03 19:32:10 | View |
| 4 | Sep 3, 2026 | 2026-09-03 19:31:06 | View |
Proxy statement (DEF 14A) disclosures